208 related articles for article (PubMed ID: 19182088)
1. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association.
Kiernan TJ; Yan BP; Cubeddu RJ; Rengifo-Moreno P; Gupta V; Inglessis I; Ning M; Demirjian ZN; Jaff MR; Buonanno FS; Schainfeld RM; Palacios IF
Stroke; 2009 Apr; 40(4):1502-4. PubMed ID: 19182088
[TBL] [Abstract][Full Text] [Related]
2. Use of Magnetic Resonance Venography in Screening Patients With Cryptogenic Stroke for May-Thurner Syndrome.
Prabhakar AM; Misono AS; Brinegar KN; Khademhosseini A; Oklu R
Curr Probl Diagn Radiol; 2016; 45(6):370-372. PubMed ID: 27338307
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Pelvic Vein Pathology in Patients with Cryptogenic Stroke and Patent Foramen Ovale Undergoing MRV Pelvis.
Osgood M; Budman E; Carandang R; Goddeau RP; Henninger N
Cerebrovasc Dis; 2015; 39(3-4):216-23. PubMed ID: 25791718
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance venography in the diagnosis and management of May-Thurner syndrome.
Wolpert LM; Rahmani O; Stein B; Gallagher JJ; Drezner AD
Vasc Endovascular Surg; 2002; 36(1):51-7. PubMed ID: 12704525
[TBL] [Abstract][Full Text] [Related]
5. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Davies A; Ekmejian A; Collins N; Bhagwandeen R
Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
[TBL] [Abstract][Full Text] [Related]
7. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
Dalen JE; Alpert JS
Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale.
Liberman AL; Daruwalla VJ; Collins JD; Maas MB; Botelho MP; Ayache JB; Carr J; Ruff I; Bernstein RA; Alberts MJ; Prabhakaran S
Stroke; 2014 Aug; 45(8):2324-9. PubMed ID: 24938843
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of patent foramen ovale determined by transesophageal echocardiography in patients with cryptogenic stroke aged 55 years or older. Same as younger patients?
Mesa D; Ruiz M; Delgado M; Suárez de Lezo J; Pan M; Tejero I; García D; Crespín M; León C; Toledano F; Mazuelos F; Ochoa JJ; Bescansa E
Rev Esp Cardiol; 2010 Mar; 63(3):315-22. PubMed ID: 20196992
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale and cryptogenic stroke in older patients.
Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
[TBL] [Abstract][Full Text] [Related]
11. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study.
Homma S; Di Tullio MR; Sacco RL; Mihalatos D; Li Mandri G; Mohr JP
Stroke; 1994 Mar; 25(3):582-6. PubMed ID: 8128511
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both.
Lim ST; Murphy SJX; Smith DR; Williams J; Navarro SG; McCabe J; Moore DP; McHugh J; McCabe DJH
J Neurol Sci; 2017 Jun; 377():227-233. PubMed ID: 28477701
[TBL] [Abstract][Full Text] [Related]
14. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
Dalen JE; Alpert JS
Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
[TBL] [Abstract][Full Text] [Related]
15. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.
Cabanes L; Mas JL; Cohen A; Amarenco P; Cabanes PA; Oubary P; Chedru F; Guérin F; Bousser MG; de Recondo J
Stroke; 1993 Dec; 24(12):1865-73. PubMed ID: 8248969
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale as a risk factor for cryptogenic stroke.
Di Tullio M; Sacco RL; Gopal A; Mohr JP; Homma S
Ann Intern Med; 1992 Sep; 117(6):461-5. PubMed ID: 1503349
[TBL] [Abstract][Full Text] [Related]
18. May-Thurner Syndrome and Patent Foramen Ovale: A Rare Etiology of Cryptogenic Stroke.
Phelps BJ; Boutin O; Patel U; King C
Cureus; 2019 Aug; 11(8):e5468. PubMed ID: 31641564
[TBL] [Abstract][Full Text] [Related]
19. Prevention of stroke in patients with patent foramen ovale.
Mattle HP; Meier B; Nedeltchev K
Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
[TBL] [Abstract][Full Text] [Related]
20. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
